How can artificial intelligence models assist PD-L1 expression scoring in breast cancer: results of multi-institutional ring studies
2021 · npj Breast Cancer · 40 citations
https://doi.org/10.1038/s41523-021-00268-y
L
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
102
Papers
1.5K
Citations
17
h-index
28
i10-index
Liang Wang is an academic researcher from First Affiliated Hospital of Guangzhou Medical University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Genomics and Phylogenetic Studies & Medical Image Segmentation Techniques. The author has an h-index of 17, co-authored 87 publications.
ORCID: 0000-0002-6981-557XPapers by this author
worksThe S100 family is a prognostic biomarker and correlated with immune cell infiltration in pan-cancer
2024 · Discover Oncology · 9 citations
https://doi.org/10.1007/s12672-024-00945-x
1570P Factors and impacts of delayed presentation for county-level patients with breast cancer in a real-life setting in China
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.08.1632
Correlation between irAEs and Efficacy of Consolidative PD-(L)1 Inhibitors Following Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer
2024 · International Journal of Radiation Oncology*Biology*Physics · 0 citations
https://doi.org/10.1016/j.ijrobp.2024.07.1824
FISHER: A Foundation Model for Multi-Modal Industrial Signal Comprehensive Representation
2025 · ArXiv.org · 0 citations
https://doi.org/10.48550/arxiv.2507.16696
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat